Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

The company recently reported that the four-protein test with algorithm-based analysis performed with 83.5 percent sensitivity and 90.3 percent specificity.

The U.S. Human Papilloma Virus (HPV) testing market is poised for significant growth, projected to reach $1.01 billion by ...

The federal government officially shut down for the first time in nearly seven years after Congress failed to pass a funding ...

The TSA has the final say on what is and isn't allowed on a flight. It has banned a type of phone before, making a ...